Propiedad y actividad de insiders de Abivax S.A. (ABVX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $106.99 |
| Capitalización | $7.9B |
| Bolsa | NASDAQ |
| País | FR |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $7.9M | $1.9M | $8.0M | $9.8M | $29.3M | $60.7M | $26.9M | $251.9M | $144.2M | $516.5M |
| Inversiones a Corto | $15.1M | $15.2M | $5.0M | $6000 | $6000 | $6000 | 0 | $9.1M | 0 | $13.7M |
| Cuentas por Cobrar | $4.8M | $3.6M | $7.8M | $7.0M | $8.0M | $8.3M | $8.3M | $19.1M | $15.7M | $10.5M |
| Inventario | $52000 | $199000 | 0 | $1.2M | 0 | $4.0M | 0 | 0 | 0 | 0 |
| Activos Corrientes | $27.8M | $20.9M | $21.0M | $18.2M | $37.7M | $75.2M | $36.2M | $286.0M | $170.7M | $551.0M |
| Inmovilizado Material | $192000 | $201000 | $151000 | $134000 | $100000 | $93000 | $1.6M | $877000 | $2.7M | $2.1M |
| Fondo de Comercio | $32.0M | $32.0M | $32.0M | $32.0M | $32.0M | $32.7M | $18.4M | $18.4M | $18.4M | $18.4M |
| Activos Intangibles | 0 | 0 | 0 | $85000 | $98000 | -$647000 | $6.6M | $6.6M | $6.6M | $6.6M |
| Activos Totales | $60.6M | $53.8M | $54.0M | $51.7M | $71.3M | $109.2M | $75.5M | $327.1M | $205.2M | $584.1M |
| Cuentas por Pagar | $2.6M | $4.2M | $6.7M | $10.5M | $17.4M | $18.6M | $15.5M | $47.2M | $43.8M | $37.6M |
| Deuda a Corto | $255000 | 0 | $10.9M | $20.7M | $12000 | $10.1M | $29.5M | $30.9M | $42.8M | $28.5M |
| Pasivos Corrientes | $3.5M | $5.4M | $8.5M | $12.4M | $19.4M | $32.3M | $51.5M | $88.1M | $92.8M | $63.0M |
| Deuda a Largo | $316000 | 0 | $10.9M | $20.7M | $34.0M | $40.3M | $8.3M | $26.6M | $52.2M | $30.2M |
| Pasivos Totales | $3.9M | $5.6M | $19.4M | $33.1M | $53.4M | $83.3M | $68.4M | $131.1M | $164.6M | $129.1M |
| Reservas | -$35.4M | -$46.6M | -$62.4M | -$93.0M | -$37.6M | -$81.8M | -$143.5M | -$282.9M | -$438.9M | -$738.2M |
| Patrimonio Neto | $56.7M | $48.2M | $34.7M | $18.6M | $17.9M | $25.9M | $7.2M | $196.0M | $40.6M | $455.0M |
| Deuda Total | $316000 | 0 | $10.9M | $20.7M | $34.0M | $51.7M | $39.2M | $58.0M | $97.4M | $45.9M |
| Deuda Neta | -$22.7M | -$17.0M | -$2.1M | $11.0M | $4.7M | -$9.0M | $12.2M | -$202.9M | -$46.9M | -$484.3M |
| Capital Circulante | $24.3M | $15.4M | $12.5M | $5.9M | $18.3M | $42.9M | -$15.3M | $197.9M | $77.8M | $488.0M |
Salud financiera
| Deuda / Patrimonio | 0.10 |
| Ratio corriente | 8.75 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 34.93 |
Rentabilidad
| Rentabilidad sobre capital | -73.87% |
| Rentabilidad sobre capital invertido | -44.70% |
| Rentabilidad sobre activos | -57.54% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: AXSM · CORT · CYTK · HALO · JAZZ · MDGL · MRUS
Explorar sector: Healthcare · Biotechnology
Más secciones de ABVX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones